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OPTIMISED	DECONJUGATION	OF	ANDROGENIC	STEROIDCONJUGATES	IN	BOVINE	URINE	
Mikael	Pedersen,	Henrik	Lauritz	Frandsen	and	Jens	Hinge	Andersen	
National	Food	Institute,	Mørkhøj	Bygade	19,	DK-2860	Søborg,	Denmark	
Abstract	
After	administration	of	steroids	to	animals	the	steroids	are	partially	metabolised	in	the	liver	and	kidney	to	phase	2	metabo-
lites	i.e.	glucuronic	acid	or	sulphate	conjugates.	During	analysis,	these	conjugated	metabolites	are	normally	deconjugated	
enzymatically	with	aryl	sulphatase	and	glucuronidase	resulting	in	free	steroids	in	the	extract.	It	is	well	known	that	some	sul-
phates	are	not	deconjugated	using	aryl	sulphatase;	instead	e.g.	solvolysis	can	be	used	for	deconjugation	of	these	aliphatic	
sulphates.	Sulphate	conjugates	of	selected	steroids	were	synthesized	by	reaction	with	excess	of	sulphur	trioxide/trimethyla-
mine	in	dimethylformamide.	The	effectiveness	of	solvolysis	on	androgenic	steroid	sulphates	is	tested	with	selected	aliphatic	
steroid	sulphates	(boldenone	sulphate,	nortestosterone	sulphate	and	testosterone	sulphate).	And	the	method	is	validated	
for	analysis	of	androgenic	steroids	in	bovine	urine	using	free	steroids,	steroid	sulphates	and	steroid	glucuronides	as	stand-
ards.	Glucuronidase	and	sulphuric	acid	in	ethylacetate	are	used	for	deconjugation	and	the	extract	is	purified	by	SPE.	The	final	
extract	is	evaporated	to	dryness,	re-dissolved	and	analysed	by	LC-MS/MS.	
Introduction	
Biotransformation	of	steroids	is	generally	divided	into	two	classes.	Phase	1	reactions	introduce	polar	functional	groups	into	
the	steroid	molecule	via	oxidation,	reduction	or	hydroxylation	to	inactivate	the	drug	and	to	increase	its	tendency	to	be	ex-
creted	from	the	body.	In	phase	2	reactions,	the	steroid	and/or	the	phase	1	metabolites	are	conjugated	with	e.g.	glucuronic	
acid	and	sulphate	forming	polar	water	soluble	products,	and	like	phase	1	compounds,	leading	to	an	increasing	tendency	to	be	
excreted	in	urine	(Schänzer	1996).	The	basic	structure	of	steroids	consists	of	the	perhydrocyclopentanophenanthrene	ring	
system	(ring	A,	B,	C	and	D).	Functional	groups	are	attached	to	the	rings	e.g.	a	hydroxy	group	on	C-3	for	sterols	or	a	carbonyl	
on	C-3	and	hydroxyl	on	C-17	for	testosterone	and	boldenone.	
	
Figure	1.	The	steroid	ring	system	with	the	IUPAC	approved	ring	lettering	(ABCD)	and	atom	numbering.	
As	a	rule	of	thumb,	the	3α-hydroxy	group	on	ring	A	(after	metabolic	reduction	of	the	3-keto	group	for	e.g.	testosterone	and	
androsterone)	are	often	conjugated	with	glucuronic	acid	and	3β-steroids	are	often	conjugated	with	sulphate.	However,	some	
3α-hydroxysteroids	are	also	excreted	as	sulphate	(like	testosterone).	In	human,	metabolism	of	testosterone	to	androsterone	
is	reported	and	androsterone	is	excreted	as	sulphate	conjugate	(Higashi	et	al.,	2007).	And	further	nortestosterone	and	a	
3β-hydroxy	metabolite	are	excreted	as	sulphate	conjugates	(Schänzer	1996;	Scarth	et	al.,	2009).	Following	the	administration	
of	nortestosterone	laurate	to	boar,	nortestosterone	sulphate	was	the	predominant	metabolite	obtained	(Ventura	et	al.,	
2008).	
Glucuronidation	of	secondary	17β-hydroxy	groups	(e.g.	testosterone,	nortestosterone	and	boldenone),	on	ring	D,	is	well	
known	and	sulphatation	is	possible	and	described	for	e.g.	testosterone,	boldenone	and	altrenogest	in	horses	(Le	Bizec	et	al.,	
2006;	Pu	et	al.,	2004;	Lampinen-Salomonsson	et	al.,	2006)	and	bovine	(Scarth	et	al.,	2009).	For	some	tertiary	17β-hydroxy	
groups	this	glucuronidation	also	takes	place	(Schänzer	1996).	In	sheep,	testosterone	is	primarily	excreted	as	glucuronide	con-
jugates	in	urine	and	sulphate	conjugates	in	bile	and	it	is	further	reported	that	in	pig	plasma	conjugated	steroids	are	mainly	
found	as	sulphate	conjugates	(Scarth	et	al.,	2009).	
Methods	for	detection	of	steroids	often	includes	a	deconjugation	step	with	enzymes,	to	convert	the	phase	2	metabolites	to	
the	free	steroid.	The	digestive	juice	of	Helix	pomatia	is	one	of	the	most	used	enzymatic	preparations	for	this,	but	this	enzyme	
preparation	does	not	contain	the	sulphatase	activity	to	hydrolyse	all	steroid	sulphates.	It	has	been	published	that	3α-hy-
droxy-5β-sulphates	(e.g.	androsterone)	and	C19-steroids	sulphated	at	C17	(e.g.	testosterone	and	boldenone)	are	resistant	to	
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this	enzymatic	hydrolysis	(Cawley	et	al.,	2005;	Schackleton	1986).	Moreover,	use	of	enzyme	mixture	can	cause	unwanted	
conversions	of	the	analytes,	e.g.	the	presence	of	oxidoreductase	activity	has	been	reported	converting	the	steroidal	3-ol	to	a	
3-oxo	group	(Hewitt	et	al.,	2002).	It	can	therefore	be	argued	that	a	chemical	deconjugation	should	be	used	for	hydrolysis	of	
steroid	sulphates	(Cawley	et	al.,	2005).	
The	method	used	in	this	study	is	based	on	the	published	method	by	Poucke	and	Van	Peteghem	(Van	Poucke	et	al.,	2002)	and	
we	have	tested	use	of	recombinant	glucuronidase	and	solvolysis	instead	of	Helix	pomatia.	The	solvolysis	was	based	on	the	
procedure	published	by	Schänzer	W.	et	al.	(1992)	with	minor	modifications.	
Not	much	has	been	published	on	testing	of	solvolysis	conditions	for	steroid	sulphates	-	Roig	et	al.	(2007)	reported	a	recovery	
of	91%	for	a	C3-conjugated	steroid	(dehydroepiandrosterone-3-sulphate).	For	testing	the	solvolysis,	we	synthesized	sulphate	
conjugates	of	selected	androgenic	steroids.	Sulphates	of	testosterone,	boldenone	and	trenbolone	were	synthesized	and	pa-
rameters	like	acidicity	and	incubation	time	were	tested.	Steroid	sulphate	conjugates	were	synthesised	by	reaction	with	ex-
cess	of	triethyamine:sulphurtrioxide	in	dimethylformamide	(Santos	et	al.,	2003)	and	steroid	glucuronides	were	biosynthe-
sised	by	incubation	with	rabbit	liver	homogenate	fortified	with	uridinediphosphoglucuronic	acid	(Mulder	et	al,	1994).	
Materials	and	Methods	
Materials	and	reagents	
All	reagents	were	of	analytical	or	HPLC	grade	and	supplied	by	Merck	(Darmstadt,	Germany)	and	Rathburn	Chemicals	(Walker-
burn,	Scotland).	Water	was	ultra-purified	using	a	Maxima	purification	system	from	USF	Elga	(Bucks,	UK).	β-nortestosterone	
(BNO)	and	testosterone	(TES)	were	purchased	from	Sigma-Aldrich,	α-trenbolone	(ATR),	β-boldenone	glucuronide,	
β-nortestosterone	glucuronide	and	α-nortestosterone	sulphate,	were	bought	from	LGC	PromoChem	(National	Analytical	Ref-
erence	Laboratory,	Australia),	α-boldenone	(ABO),	β-boldenon	(BNO),	β-trenbolone	(BTR),	α-nortestosterone	(ANO),	β-bol-
denone	sulphate,	testosterone-d2	(TES-d2),	β-Boldenone-d3	(BBO-d3),	β-nortestosterone-d3	(BNO-d3)	and	β-trenbolone-d3	
(BTR-d3)	were	from	RIKILT	(Wageningen,	The	Netherlands).	Testosterone	sulphate	was	synthesized	from	testosterone	accord-
ing	to	the	procedure	described	later.	Stock	solutions	of	each	compound	were	prepared	separately	in	ethanol	at	concentra-
tions	of	1	mg	mL-1.	Stock	solutions	of	internal	standards,	however,	were	prepared	by	reconstitution	of	ampoules	containing	a	
fixed	amount	of	material	with	ethanol	at	a	concentration	of	0.1	mg	mL-1.	Stock	solutions	were	stored	at	–18°C	until	use	for	up	
to	3	year.	A	final	working	solution	containing	all	the	compounds	at	0.1	µg	mL-1,	except	internal	standards,	was	prepared	by	
diluting	stock	solutions	with	ethanol.	A	final	working	solution	of	internal	standards	containing	all	four	internal	standards	at	
0.1	µg	mL-1	was	also	prepared	by	diluting	stock	solutions	with	ethanol.	Final	working	solutions	were	freshly	made.	Samples	
were	cleaned	up	on	C18	SPE-columns	(500	mg,	3	mL,	Waters	Corp.	Milford,	MA,	USA)	and	filtered	through	NH2	SPE	columns	
(500	mg,	5	mL,	Waters	Corp.).	
Syntheses	of	steroid	sulphates	
An	amount	of	0.1	mg	each	of	testosterone,	β-trenbolone	and	boldenone	was	dissolved	in	1	mL	of	dry	dimethylformamide	
and	each	added	a	spoon	(approximately	20	mg)	of	triethylamine:sulphurtrioxide.	The	reaction	mixtures	were	left	overnight	at	
room	temperature.	The	reaction	mixtures	were	each	added	4	mL	water	and	applied	on	activated	and	washed	Isolute	101	SPE	
columns	(100	mg,	Biotage,	Sweden).	After	washing	with	water	the	columns	were	eluted	with	1	mL	of	methanol	and	1	mL	of	
ethyl	acetate.	The	eluates	were	evaporated	to	dryness.	
Biosyntheses	of	steroid	glucuronides.	
Three	vials	containing	0.01	mg	each	of	testosterone,	β-trenbolone	and	boldenone	in	10	µL	methanol	were	each	added	1	mL	
of	rabbit	liver	homogenate	(2	mg	protein	mL-1)	and	2	mg	uridinediphosphoglucuronic	acid	(UDPGA)	and	incubated	at	37oC	
with	gentle	shaking	for	1	h.	The	incubation	mixtures	were	applied	on	activated	and	washed	Isolute	101	SPE	columns	(100	mg,	
Biotage,	Sweden).	After	washing	with	water,	the	columns	were	eluted	with	1	mL	50%	methanol.	The	eluates	were	evapo-
rated	to	dryness.	
Samples	
Urine	was	collected	at	slaughterhouses,	as	part	of	the	national	plan	for	monitoring	drug	residues	in	animals	and	animal	prod-
ucts.	As	soon	as	the	samples	were	received,	they	were	stored	at	–18°C	until	analysis.	
Sample	preparation	
To	1	mL	of	urine,	1	mL	MOPS	buffer	(50mM,	pH	7)	and	250	U	of	glucuronidase	(type	VII-A,	Sigma)	were	added.	After	addition	
of	200	µL	internal	standard	working	solution	(20	ng)	the	sample	was	incubated	at	37oC	for	1	h.	The	sample	was	applied	to	the	
C18	SPE-column	(500	mg)	pre-activated	with	5	mL	of	methanol	and	subsequently	by	5	mL	of	water.	After	washing	with	3	mL	
water,	the	column	was	vacuum-dried	for	2	min.	The	analytes	were	eluted	from	the	column	with	3	mL	methanol.	The	extract	
was	dried	using	a	nitrogen	evaporator	at	40°C	and	reconstituted	with	1	mL	of	ethylacetate	and	40	µL	4	M	H2SO4	followed	by	
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incubation	at	40oC	for	30	min.	After	addition	of	320	µL	1	M	tris-buffer	the	organic	phase	was	evaporated	at	40oC	using	nitro-
gen.	One	mL	20%	methanol	was	added	and	vortexed.	The	sample	was	applied	to	a	new	C18	SPE-column	(500	mg)	activated	
with	5	mL	methanol	and	subsequently	by	5	mL	water	prior	to	use.	After	washing	with	3	mL	water	and	3	mL	30%	methanol,	
the	column	was	vacuum-dried	for	2	min.	The	analytes	were	eluted	from	the	column	with	4	mL	ethylacetate.	The	extract	was	
filtered	through	a	NH2	SPE-column	(500	mg)	from	Waters,	activated	with	6	mL	ethylacetate	before	use.	The	extract	was	dried	
using	a	nitrogen	evaporator	at	40°C.	The	residue	was	reconstituted	in	400	µL	methanol/water/formic	acid	(25/75/0.1).	
LC-MS/MS	analysis	
HPLC	separation	was	performed	on	an	Agilent	1100	series	LC	system	from	Agilent	Technologies	(Palo	Alto,	CA,	USA)	equipped	
with	a	high-pressure	binary	pump,	degasser,	auto	sampler	and	a	column	heater.	The	steroids	were	separated	on	an	Ascentis	
express	C8	column	(2.1mm*100mm,	1.8µm)	from	Supelco	at	30°C	using	a	gradient	method	(0	min:	90%	A;	0.5	min:	75%	A;	15	
min:	65%	A;	20	min:	10%	A).	Mobile	phase	A	contained	0.1%	formic	acid	in	water	and	mobile	phase	B	contained	acetonitrile,	
and	the	flow	rate	was	set	at	0.25	mL	min-1.	The	sample	volume	injected	was	10	µL.	
The	mass	spectrometer	was	a	Quattro	Ultima	Pt	triple	quadropole	instrument	(Waters	Corp.)	with	Masslynx	v.	4.1	software	
(Waters	Corp.).	Ionisation	of	the	analytes	was	achieved	using	an	electrospray	interface	in	the	positive	ion	mode	(ESI+),	and	
ionisation	source	parameters	were	as	follows:	capillary	voltage	(Vcap),	3.75	kV;	cone	voltage	(Vcone),	35	V;	desolvation	temper-
ature,	400°C;	source	temperature,	120°C.	Nitrogen	was	used	as	the	nebulising	gas	(maximum	flow),	desolvation	gas	(flow-
rate	of	600	L	h-1),	and	as	cone	gas	(flow-rate	of	120	L	h-1).	Argon	was	used	as	the	collision	gas	at	a	pressure	of	~	2.5	⋅	10-3	
mbar.	Data	acquisition	was	performed	in	the	multiple	reaction	monitoring	(MRM)	mode.	MRM	transitions	and	collision	ener-
gies	for	the	analytes	are	listed	in	Table	1,	and	the	dwell	time	was	set	to	0.1	s	for	every	transition.	
Matrix-matched	standards	were	used	to	quantify	the	analytes.	The	fortification	levels	of	the	validation	curves	were:	0.0	
(blank	sample),	0.5,	1.0,	2.0,	5.0	and	10.0	µg	L-1.	A	fixed	amount	of	internal	standard	(20	µg	L-1)	was	added	to	all	the	samples.	
Calibration	curves	were	obtained	relating	relative	responses	of	the	analyte	(chromatographic	peak	area	of	the	analyte	at	dif-
ferent	concentration	levels	in	relation	to	the	concentration	of	the	internal	standard	divided	by	the	peak	area	of	the	internal	
standard)	versus	nominal	concentrations	(µg	L-1)	of	the	analytes.	As	a	deuterated	labelled	standard	was	not	available	for	
some	steroids	a	deuterated	epimer	standard	was	used.	BBO-d3	was	used	as	an	internal	standard	for	ABO,	BTR-d3	was	used	as	
an	internal	standard	for	ATR	and	BNO-d3	was	used	as	an	internal	standard	for	ANO.	
Table	1.	Data	acquisition	method	for	analysis	by	LC-MS/MS.	
Name	(abbreviation)	 MRM	transition	(m/z)a	 Collision	energy	(eV)	
Testosterone	(TES)	
289.1>97.1	
(289.1>109.1)	
18	
20	
α-Boldenone/β-Boldenone	(ABO/BBO)	
287.2>121.1	
(287.2>135.1)	
18	
15	
α-	Trenbolone/β-Trenbolone	(ATR/BTR)	
271.2>199.1	
(271.2>253.2)	
20	
20	
α-	Nortestosterone/β-	Nortestosterone	(ANO/BNO)	
275.2>109.1	
(275.2>239.2)	
22	
17	
Testosterone-d2	(TES-	d2)	 291.1>99.1	 18	
β-Boldenone-d3	(BBO-d3)	 290.2>121.1	 15	
β-Trenbolone-d3	(BTR-d3)	 274.3>256.0	 20	
β-	Nortestosterone-d3	(BNO-d3)	 278.2>109.1	 22	
a	Primary	MRM	transitions	used	for	quantitative	purposes	are	listed	first,	and	secondary	MRM	transitions	for	confirmation	are	in	parenthe-
ses.	
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Results	and	Discussion	
Since	some	steroid	conjugates	are	not	commercially	available,	we	synthesized	selected	steroid	sulphates	by	reaction	of	the	
parent	compound	with	trimethylamine:sulphurtrioxide	and	biosynthesized	selected	steroid	glucuronides	by	incubation	of	the	
parent	compound	with	rabbit	liver	homogenate	fortified	with	UDPGA.	These	conjugates	were	used	in	the	optimization	of	
hydrolysis	conditions.	
	
Figure	2.	Acid	hydrolysis	of	boldenone	sulphate	to	A:	0	min	and	B,C:	30	min.	Samples	were	analysed	on	an	Agilent	1100	HPLC	connected	to	
an	Bruker	Daltonics	Esquire	HCT	ion	trap	mass	spectrometer	equipped	with	an	ESI	ion	source	operated	in	positive	mode.	D:	Stability	of	bol-
denone	during	prolonged	hydrolysis	time.	
Solvolysis	was	investigated	by	optimising	the	concentration	of	sulphuric	acid	and	time	of	incubation	at	40oC.	After	addition	of	
ethylacetate	and	4	M	sulphuric	acid	the	decay	of	boldenone	sulphate	was	monitored	by	HPLC-MS	to	various	time	points.	Fig-
ure	2	(panel	A)	shows	the	extracted	ion	chromatogram	of	boldenone	sulphate	(m/z=367)	to	time	0.	After	30	min	of	hydroly-
sis,	a	boldenone	peak	appeared	(m/z=287)	and	Figure	2	(panel	B	and	C)	shows	that	boldenone	sulphate	was	hydrolysed	after	
30	min	of	incubation.	The	stability	of	β-boldenone	during	the	hydrolysis	reaction	for	prolonged	hydrolysis	time	was	investi-
gated	for	up	to	24	h.	Fig.	2	(panel	D)	shows	that	the	concentration	of	β-boldenone	decreases	with	increasing	incubation	time.	
	
Figure	3.	Enzymatic	hydrolysis	of	biosynthesised	boldenone	glucuronide.	A,	B:	extracted	ion	chromatograms	of	boldenone	glucuronide	and	
boldenone	to	time	0.	C,	D:	extracted	ion	chromatograms	obtained	after	1	hour	of	hydrolysis.	
After	2	hours	of	incubation,	only	80%	β-boldenone	was	recovered	and	after	24	hours	only	20%	was	recovered.	Concentra-
tions	of	1,	2,	3	and	4	M	sulphuric	acid	were	tested;	4	M	gave	the	best	results	(results	not	shown).	
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Figure	3	shows	the	extracted	ion	chromatograms	obtained	prior	to	and	after	enzymatic	hydrolysis	with	β-glucuronidase	from	
E.	coli	of	the	biosynthesised	boldenone	glucuronide.	Panels	A	and	B	show	the	chromatograms	prior	to	hydrolysis,	the	glucu-
ronide	with	m/z=	463	elutes	at	6	min	and	a	minor	peak	or	unconjugated	boldenone	elutes	to	7.5	min.	After	hydrolysis	for	one	
hour	(panel	C	and	D)	the	boldenone	glucuronide	peak	has	disappeared	and	the	boldenone	peak	has	increased	in	intensity.	
For	testing	the	deconjugation	procedure	on	bovine	urine	samples,	we	used	our	originally	validated	method	for	steroids	in	
urine	where	Helix	pomatia	is	used	for	enzymatic	hydrolysis	of	steroid	conjugates.	The	enzymatic	step	was	changed	by	using	
β-glucuronidase	(type	VII-A)	for	hydrolysing	steroid	glucuronides	and	the	sulphates	were	released	by	hydrolysis	under	acidic	
conditions	with	4	M	sulphuric	acid.	
An	estimate	of	the	concentration	of	our	synthesized	testosterone	sulphate	was	calculated	by	using	the	deconjugation	proce-
dure	on	a	fixed	volume	of	the	synthesized	standard	and	the	concentration	of	testosterone	in	the	extract	was	estimated	from	
the	calibration	curve	from	analysis	of	a	standard	of	unconjugated	testosterone.	
	
Figure	4.	Chromatograms	of	blank	bovine	urine	sample	spiked	with	6	µg	L-1	boldenone	glucuronide	(A),	nortestosterone	glucuronide	(B),	
boldenone	sulphate	(C)	and	15	µg	L-1	testosteron	sulphate	(D).	
Table	2.	Repeatability,	intra-laboratory	reproducibility	and	recovery	in	spiked	samples	of	bovine	urine.	
Name	
Nominal	
Concentration	
(µg	L-1)	
	
Repeatabil-
ity	
(%RSDr)	
Intra-laboratory	
Reproducibility	
(%RSDIR)	
	
N	
	
Recovery	
(%)	
α-Boldenone	 1.0-5.0	 11	 11	 24	 96	
β-Boldenone	 1.0-5.0	 10	 10	 24	 100	
α-Nortestosterone	 1.0-5.0	 18	 18	 24	 98	
β-Nortestosterone	 1.0-5.0	 18	 14	 20	 92	
α-Trenbolone	 1.0-5.0	 12	 14	 24	 98	
β-Trenbolone	 1.0-5.0	 13	 22	 24	 98	
β-Boldenone	sulphate	 3.0-30.0	 13	 14	 16	 57	
α-Nortestosterone	sulphate	 3.0-30.0	 14	 23	 16	 52	
Testosterone	sulphatea	 7.5-75	 7	 14	 18	 50	
β-Boldenone	glucuronide	 6.0	 8	 12	 6	 78	
β-Nortestosterone	glucuronide	 6.0	 12	 12	 6	 99	
a	Concentration	of	in-house	synthesized	testosterone-sulphate	estimated	according	to	the	procedure	described	in	the	text.	
	 6	
	
The	method	was	validated	according	to	the	EU	legislation	(Commission	Decision	2002/657/EC,	2002)	and	analytes	were	
quantified	using	spiked	samples	i.e.	bovine	urine	spiked	with	analytes	and	deuterated	internal	standards,	prior	to	sample	
preparation.	For	calculation	of	precision	and	recovery,	three	concentration	levels	were	selected	for	the	unconjugated	ster-
oids	(1,	2	and	5	µg	L-1)	and	sulphate	conjugated	steroids	(3,	6	and	30	µg	L-1)	and	one	concentration	level	for	the	glucuronide	
conjugated	steroids	(6	µg	L-1)	–	for	testosterone	sulphate,	though,	the	concentration	levels	were	7.5,	15	and	75	µg	L-1.		In	Fig-
ure	4	the	chromatograms	are	shown	for	two	urine	samples	spiked	with	either	glucuronides	(panel	A	and	B)	or	sulphates	
(panel	C	and	D)	of	steroids.	
The	residuals	and	determination	coefficient	were	acceptable	(r2	>	0.95)	and	specificity	is	acceptable	since	no	interferences	
are	occurring	where	the	analytes	are	eluting.	Decision	limit,	CCα,	and	detection	capability,	CCβ,	is	not	significantly	different	
from	the	originally	method	and	are	below	1.0	µg	L-1.	The	precision	is	acceptable	for	all	tested	analytes	(Table	2).	The	accu-
racy,	calculated	as	recovery	for	the	spiked	samples,	is	acceptable	for	the	free	steroids,	78	and	99%	for	the	tested	glucuron-
ides	and	50-57%	for	the	three	sulphates	tested,	taking	into	account	the	mass	equivalence	of	steroid	from	steroid	conjugate.	
Conclusion	
A	method	has	been	presented	that	provides	detection	of	androgenic	steroids	and	phase	2	metabolites	of	these	in	bovine	
urine.	The	conditions	for	hydrolysis	of	glucuronides	and	especially	sulphates	have	been	optimised	and	validated	and	proce-
dures	for	synthesis	of	glucuronide-	and	sulphate	conjugates	of	steroids	has	been	presented.	Hydrolysis	of	sulphate	conju-
gates,	not	hydrolysed	by	normally	used	enzyme	preparations,	is	possible	with	acceptable	results.	
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